VAYBIC Trademark

Trademark Overview

On Wednesday, December 1, 2021, a trademark application was filed for VAYBIC with the United States Patent and Trademark Office. The USPTO has given the VAYBIC trademark a serial number of 97150742. The federal status of this trademark filing is SUSPENSION INQUIRY - MAILED as of Friday, January 17, 2025. This trademark is owned by Sun Pharma Advanced Research Company Limited. The VAYBIC trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of ophthalmic diseases and disorders
vaybic

General Information

Serial Number97150742
Word MarkVAYBIC
Filing DateWednesday, December 1, 2021
Status651 - SUSPENSION INQUIRY - MAILED
Status DateFriday, January 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of ophthalmic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSun Pharma Advanced Research Company Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMumbai 400093
IN

Trademark Events

Event DateEvent Description
Saturday, December 4, 2021NEW APPLICATION ENTERED
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 9, 2022ASSIGNED TO EXAMINER
Saturday, August 13, 2022SUSPENSION LETTER WRITTEN
Saturday, August 13, 2022LETTER OF SUSPENSION E-MAILED
Saturday, August 13, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 10, 2023SUSPENSION INQUIRY WRITTEN
Friday, February 10, 2023INQUIRY TO SUSPENSION E-MAILED
Friday, February 10, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, May 8, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 27, 2023ASSIGNED TO LIE
Wednesday, September 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 4, 2023SUSPENSION LETTER WRITTEN
Wednesday, October 4, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, October 4, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, April 2, 2024SUSPENSION INQUIRY WRITTEN
Tuesday, April 2, 2024INQUIRY TO SUSPENSION E-MAILED
Friday, June 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 2, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, July 11, 2024SUSPENSION LETTER WRITTEN
Thursday, July 11, 2024LETTER OF SUSPENSION E-MAILED
Friday, January 17, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, January 17, 2025INQUIRY TO SUSPENSION E-MAILED
Friday, January 17, 2025SUSPENSION INQUIRY WRITTEN
Friday, June 28, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 11, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Related Keywords

vaybic diseases disorders ophthalmic treatment preparations substances pharmaceutical